Bradley Merrill Thompson, Member of the Firm, will join a panel discussion on FDA oversight at the Radcliffe Exploratory Seminar on Mobile Health.
This seminar explores how mobile health technologies, including "medical apps" for smartphones and tablets, might change health care in the United States, including how we deliver, measure, consume, pay for, and regulate health care. It examines the legal, regulatory, and ethical implications from the perspective of various disciplines, including law, medicine, government, and public policy. Several federal agencies are actively involved in the mobile health space, and Congress is considering multiple bills to confront these technologies. This seminar provides an intense two-day discussion among experts in these fields in the hopes of generating inputs to help guide future policymaking and scholarship.
For more information, visit Radcliffe Exploratory Seminars.
